LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Clinical trials for LOCALLY ADVANCED OR METASTATIC BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC BREAST CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to keep advanced breast cancer at bay
Disease control OngoingThis study is for people with a specific type of advanced breast cancer (HER2-positive and estrogen receptor-positive) that has not been treated before. It tests if adding a new drug called giredestrant to a standard two-drug therapy (Phesgo) works better than using the standard …
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New drug combo tested for Tough-to-Treat breast cancer
Disease control OngoingThis study is testing whether adding a new drug called capivasertib to an existing hormone therapy (fulvestrant) can help control advanced breast cancer that has specific genetic changes and has started growing again after standard treatments. It will involve about 101 patients i…
Matched conditions: LOCALLY ADVANCED OR METASTATIC BREAST CANCER
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC